These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 629547)

  • 1. Selective immunological evaluation of mycosis fungoides.
    Cooperrider PA; Roenigk HH
    Arch Dermatol; 1978 Feb; 114(2):207-12. PubMed ID: 629547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunological profile of mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K; Ahrons S; Zachariae H
    Clin Exp Immunol; 1982 Nov; 50(2):397-405. PubMed ID: 6983938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic evaluation in mycosis fungoides. Before and after PUVA therapy.
    Kubba R; Bailin PL; Roenigk HH
    Arch Dermatol; 1980 Feb; 116(2):178-81. PubMed ID: 6965577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T- and B-cells and IgE in mycosis fungoides.
    Zachariae H; Ellegaard J; Grunnet E; Søgaard H; Thulin H
    Acta Derm Venereol; 1975; 55(6):466-8. PubMed ID: 55039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed lymphokine activated killer cell activity in mycosis fungoides. A possible marker for aggressive disease.
    Wood NL; Kitces EN; Blaylock WK
    Arch Dermatol; 1990 Jul; 126(7):907-13. PubMed ID: 2360838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serum of mycosis fungoides patients on lymphocyte transformation.
    Kinoshita M; Kawada A
    J Dermatol; 1976 Aug; 3(4):115-9. PubMed ID: 15633964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
    Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
    Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K
    Acta Derm Venereol; 1980; 60(2):159-61. PubMed ID: 6155025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides.
    Kragballe K; Herlin T; Ellegaard J
    Arch Dermatol; 1983 Mar; 119(3):203-6. PubMed ID: 6824357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte abnormalities in mycosis fungoides.
    MacKie R; Sless FR; Cochran R; De Sousa M
    Br J Dermatol; 1976 Feb; 94(2):173-8. PubMed ID: 1082769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IgE and cellular immunity in cutaneous lymphomas (author's transl)].
    Guilhou JJ; Clot J; Robinet-Lévy M; Meynadier J
    Ann Dermatol Venereol; 1977; 104(8-9):533-7. PubMed ID: 303883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycosis fungoides. Peripheral T cell subsets defined by specific monoclonal antibodies.
    Valsecchi R; Reseghetti A; Bontempelli M; Frigeni A; Cainelli T
    Dermatologica; 1984; 169(1):12-7. PubMed ID: 6236114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogens of B and T cells from peripheral blood in rheumatoid arthritis.
    Clot J; Mathieu O; Sany J; Serre H
    Rheumatology; 1975; 6():199-208. PubMed ID: 1081725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides with a CD56+ immunophenotype.
    Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R
    J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell characterization in mycosis fungoides.
    Robinowitz BN; Noguchi S; Roenigk HH
    Cancer; 1976 Apr; 37(4):1747-53. PubMed ID: 1083287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders.
    Zachariae C; Larsen CS; Kaltoft K; Deleuran B; Larsen CG; Thestrup-Pedersen K
    Acta Derm Venereol; 1991; 71(6):465-70. PubMed ID: 1685826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.